ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Reckitt Benckiser PLC (PK)

Reckitt Benckiser PLC (PK) (RBGLY)

11.37
0.22
(1.97%)
Closed March 28 04:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
11.37
Bid
11.35
Ask
11.40
Volume
958,729
11.31 Day's Range 11.42
0.00 52 Week Range 0.00
Market Cap
Previous Close
11.15
Open
11.38
Last Trade
96
@
11.37
Last Trade Time
Financial Volume
$ 10,881,697
VWAP
11.3501
Average Volume (3m)
-
Shares Outstanding
736,535,179
Dividend Yield
-
PE Ratio
20.10
Earnings Per Share (EPS)
2.25
Revenue
14.61B
Net Profit
1.66B

About Reckitt Benckiser PLC (PK)

Sector
Soap And Other Detergents
Industry
Soap,detergent,toilet Preps
Website
Headquarters
Berkshire, Gbr
Founded
1953
Reckitt Benckiser PLC (PK) is listed in the Soap And Other Detergents sector of the OTCMarkets with ticker RBGLY. The last closing price for Reckitt Benckiser (PK) was $11.15. Over the last year, Reckitt Benckiser (PK) shares have traded in a share price range of $ 0.00 to $ 0.00.

Reckitt Benckiser (PK) currently has 736,535,179 shares outstanding. The market capitalization of Reckitt Benckiser (PK) is $33.31 billion. Reckitt Benckiser (PK) has a price to earnings ratio (PE ratio) of 20.10.

RBGLY Latest News

Indivior Says UK High Court Strikes Claims Against It and Reckitt Benckiser

By Christian Moess Laursen Indivior said the U.K. high court has removed securities claims against the company and Reckitt Benckiser in separate legal cases regarding misleading statements. The...

Reckitt Benckiser Chair Chris Sinclair to Retire; Jeremy Darroch Named Successor

By Joe Hoppe Reckitt Benckiser said Chair Chris Sinclair intends to retire after the 2024 annual general meeting in May, and named Senior Independent Director Jeremy Darroch as his successor. The...

Reckitt Benckiser Backs 2023 View, Starts GBP1 Billion Share Buyback -- Update

By Michael Susin and Joe Hoppe Reckitt Benckiser backed its revenue growth expectations for the full year despite slightly missing third-quarter market expectations, and kicked off a 1 billion...

Reckitt Benckiser Backs 2023 View, Starts GBP1 Billion Share Buyback

By Michael Susin and Joe Hoppe Reckitt Benckiser backed its revenue growth expectations for the full year despite slightly missing third-quarter market expectations, and kicked off a 1 billion...

Reckitt Benckiser CFO to Retire; Nike's Shannon Eisenhardt Named as Replacement -- Update

By Christian Moess Laursen Reckitt Benckiser Group's Chief Financial Officer Jeff Carr plans to step down on March 31 and will be replaced by Nike's Shannon Eisenhardt. The...

Reckitt Benckiser CFO to Retire; Shannon Eisenhardt Tapped as Replacement

By Christian Moess Laursen Reckitt Benckiser Group said Chief Financial Officer Jeff Carr will step down on March 31, and that Shannon Eisenhardt will take up the role on Oct. 17. The...

Correction to Reckitt Benckiser EPS Flash Headlines on July 26

Reckitt Benckiser Group has reported earnings per share for the first half of 172.8 pence and 171.6 pence from continuing operations. "Reckitt Benckiser Group PLC 1H EPS 8p," and...

Reckitt Benckiser 1st Half Pretax Profit Fell Despite Price Growth; Backs Revenue Guidance

By Joe Hoppe Reckitt Benckiser Group said Wednesday that pretax profit for the first half of the year slipped despite a rise in revenue, as volumes slipped and operating expenses rose, and backed...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
QLIQilian International Holding Group Ltd
$ 1.11
(60.89%)
2.63M
GRTXGalera Therapeutics Inc
$ 0.177
(26.43%)
895.25k
SBFMSunshine Biopharma Inc
$ 0.0721
(19.17%)
23.73M
MEDPMedpace Holdings Inc
$ 480.00
(18.77%)
1.21k
JSPRWJasper Therapeutics Inc
$ 0.2147
(17.97%)
600
XTKGX3 Holdings Company Ltd
$ 0.657
(-33.64%)
1.21M
NVVENuvve Holding Corporation
$ 0.811
(-26.27%)
105.92k
NDRAENDRA Life Sciences Inc
$ 0.45
(-22.41%)
111.07k
VVOSVivos Therapeutics Inc
$ 3.81
(-21.12%)
36.59k
APLTApplied Therapeutics Inc
$ 5.60
(-17.65%)
272.06k
SBFMSunshine Biopharma Inc
$ 0.0721
(19.17%)
23.73M
CRKNCrown Electrokinetics Corporation
$ 0.0601
(0.33%)
5.77M
AAPLApple Inc
$ 171.34
(-0.08%)
3.54M
JAGXJaguar Health Inc
$ 0.0877
(-2.45%)
2.82M
QLIQilian International Holding Group Ltd
$ 1.11
(60.89%)
2.63M

RBGLY Discussion

View Posts
jgrabar jgrabar 4 years ago
Anyone long on the LSE shares of RB.?
👍️0
Rigor Rigor 4 years ago
Slow moving but this will pop.
👍️0
Rigor Rigor 4 years ago
Crazy right. Thought this thing would be going like wildfire. I'll give it year. Will be up 1000 percent.
👍️0
airsplash2000 airsplash2000 4 years ago
Good news out yesterday! Volume is building. This is a sleeping giant, just be patient.
👍️0
Rigor Rigor 4 years ago
Still quiet here. I dont get it....
👍️0
airsplash2000 airsplash2000 4 years ago
Why is this on OTC? Any chance of uplisting?
👍️0
CashMoneyNY CashMoneyNY 4 years ago
Hello anybody here lol
👍️0
airsplash2000 airsplash2000 4 years ago
This stock must be the best kept secret of the pandemic!
👍️0
Rigor Rigor 4 years ago
My thoughts as well.
👍️0
DocBlkAdr DocBlkAdr 4 years ago
I can't believe nobody is talking about this company now.
👍️0
nuketheshorts nuketheshorts 6 years ago
In 1999, European firms Reckitt & Coleman and Benckiser combined to form Reckitt Benckiser. Based out of the United Kingdom, the company owns a portfolio of consumer products that are well-known around the globe, many of which have the leading or number-two position in their categories.

In 2017, total sales grew 21% to more than $14.8 million, making Reckitt Benckiser the top performer in sales growth among its peers (revenue growth among its peers grew an average of 6%). A big driver of that revenue growth came from its February 2017 acquisition of baby formula company Mead Johnson Nutrition, which I'll cover in more detail further on.

The company classifies itself into two main categories: Health and Hygiene Home, under which the company boasts 21 "power brands," or brands that are at the top of their category.

Under its Health segment, the company boasts industry-leading products such as Scholl footcare products, Mucinex cold and flu medicine, Clearasil acne treatment, Strepsils throat lozenges, Nurofen pain relief medication and Durex condoms. A couple of examples of the firm's market-leading products can be seen in Nurofen, which is the number-one painkiller in the United Kingdom with roughly 25% market share and is a close number two in Australia with 22% share. Mucinex is another example, as it's the number-one cough brand in the United States.

In 2017, its Health segment pulled in more than $6.5 billion in sales, accounting for about 44% of total sales. This segment will continue to see strong growth as its Mead Johnson acquisition falls under this category. And Mead Johnson's baby formula holds a near 30% market share in the United States.

Reckitt Benckiser's Hygiene Home division includes top brands like cleaning and disinfecting brand Lysol, Woolite laundry detergent, stain remover Vanish and dishwasher detergent Finish. This division generated more than $7.9 billion in sales in 2017.
👍️0

Your Recent History

Delayed Upgrade Clock